- An antiviral tablet from Japan called Avigan that’s normally used to treat influenza is getting a closer look for being a possible treatment option for people suffering from the COVID-19 coronavirus.
- The company that makes the drug is in the midst of ramping up production, which comes as a clinical trial with the drug is underway in the US – and companies around the world are racing to find treatments and ultimately a vaccine with which to finally get the coronavirus pandemic under control.
- Visit BGR’s homepage for more stories.
Production of an antiviral tablet from Japan called Avigan that’s being tested as a treatment for the COVID-19 coronavirus is ramping up, following the launch of a Phase 2 clinical trial of the drug in the US.
The drug, also known as favipiravir and manufactured by Fujifilm Corp., has actually been approved for manufacturer and sale in Japan since 2014, when it was used to fight influenza. The company announced in recent days that as part of ramping up production of the drug, it will be allocating extra capacity at a facility in Japan to manufacture Avigan — and the company has also completed a number of deals necessary with international companies to source raw materials and pharmaceutical supplies needed to make the drug.
Today’s Top Deals
- Today’s top deals: Crazy Fire HD 8 Tablet deal, AirPods Pro and AirPods 2 at new lowest price, coronavirus killer, more
- AirPods too pricey even on sale? Pick up these great rival earbuds for $22
- Last chance to get the most incredible Fire HD 8 Tablet deal we’ve ever seen
Trending Right Now:
- Where’s my stimulus check? 4 reasons why it hasn’t arrived yet
- Here’s the federal government’s plan for reopening the country, starting in May
- CDC director says another coronavirus wave is coming
Coronavirus update: Production of antiviral tablet ramping up after US clinical trial originally appeared on BGR.com on Fri, 17 Apr 2020 at 18:59:02 EDT. Please see our terms for use of feeds.
Read more here:: Boy Genius Report